New CAR-T Therapy Shows 100% Response Rate in Multiple Myeloma Trial
A Phase 1 clinical trial published in the New England Journal of Medicine revealed that an investigational CAR-T cell therapy, anito-cel, achieved a 100% overall response rate in 38 evaluable … Read More